NCT06838624Not yet recruiting
RedCord in Neurogenic Bowel Dysfunction in Multiple Sclerosis
Effectiveness of Treatment With RedCord in Neurogenic Bowel Dysfunction in People With Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 24 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study aims to evaluate the effectiveness of Redcord treatment for neurogenic bowel dysfunction in patients with multiple sclerosis. The main objectives are: * Assess the impact of Redcord on bowel function and quality of life in multiple sclerosis patients. * Compare the outcomes of Redcord treatment with standard care practices. Participants will undergo Redcord therapy sessions and their bowel function will be monitored and compared to a control group receiving standard care. The study will measure improvements in bowel control, frequency, and overall patient satisfaction.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 76 (estimated)
- First submitted
- 17 Feb 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- University of Castilla-La Mancha
- Diseases
- Multiple sclerosis
- NCT number
- NCT06838624
What you commit to
- Study type: Interventional
- Planned participants: 76
- From 1 Sept 2025 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- People with cognitive impairment, which makes it difficult to understand the questionnaires properly.
- Severe psychological or psychiatric pathology diagnosed.
Other
- Pregnant women.
Who the study is looking for
- People diagnosed with Multiple Sclerosis according to McDonald's criteria.
- EDSS less than 6 points.
- Willingness to participate.
Age in the registry: 30 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Castilla La Macha Coordinator of this site? Confirm its status | Toledo | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.